NR2F1 and breast carcinoma: In breast cancer, we found miRNA‐338‐3p, as the target binding miRNA of lncRNA NR2F1‐AS1, could probably exert angiogenetic effects according to bioinformatics prediction, which was consistent with the results in hepatocellular carcinoma.